MONMOUTH JUNCTION, N.J., Nov. 1, 2016 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® extracorporeal cytokine adsorber to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report Q3 2016 financial results after the market close on Monday, November 7, 2016.
CytoSorbents' management will host a live conference call and presentation webcast that will recount both operational and financial progress during Q3 2016 followed by a question and answer session.
Conference Call Details:
Date: Monday, November 7, 2016
Time: 4:45 PM Eastern
Participant Dial-In: 1-719-457-2605
Live Presentation Webcast:
It is recommended that participants dial in approximately 10 minutes prior to the start of the call. There will also be a simultaneous live webcast of the conference call that can be accessed through the following audio feed link:
An archived recording of the conference call will be available under the Investor Relations section of the Company's website at
About CytoSorbents Corporation